Hetero Labs Limited — Sitagliptin Exporter Profile
Indian Pharmaceutical Exporter · #4 for Sitagliptin · $2.8M export value · DGFT Verified
Hetero Labs Limited is the #4 Indian exporter of Sitagliptin with $2.8M in export value and 56 verified shipments. Hetero Labs Limited holds a 3.7% market share in Sitagliptin exports across 7 countries. The company exports 46 pharmaceutical products worth $319.3M across 18 therapeutic categories.
Hetero Labs Limited — Sitagliptin Export Profile: Buyers & Destinations
Where Does Hetero Labs Limited Export Sitagliptin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MEXICO | $1.6M | 32 | 86.0% |
| UNITED KINGDOM | $166.8K | 7 | 9.1% |
| NETHERLANDS | $72.7K | 4 | 3.9% |
| MALTA | $9.6K | 2 | 0.5% |
| BOTSWANA | $8.5K | 3 | 0.5% |
| RUSSIA | $104 | 2 | 0.0% |
| BRAZIL | $0 | 6 | 0.0% |
Hetero Labs Limited exports Sitagliptin to 7 countries. The largest destination is MEXICO accounting for 86.0% of Hetero Labs Limited's Sitagliptin shipments, followed by UNITED KINGDOM (9.1%) and NETHERLANDS (3.9%). These destinations reflect Hetero Labs Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Sitagliptin from Hetero Labs Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| XXAROXXPHAXXA XXA XX C XX | MEXICO | $1.0M | 20 |
| XXAROXXPHAXXA SXX DXXC VX | MEXICO | $583.4K | 12 |
| XXAROXXLIMXXED | UNITED KINGDOM | $166.8K | 7 |
| XXAROXXPHAXXA BXX | NETHERLANDS | $51.9K | 3 |
| XXAROXXPHAXXA GXXH | NETHERLANDS | $20.7K | 1 |
| XXUMAXXPHAXXA GXXH ANDXXO XXNERXXA KX | MALTA | $9.6K | 2 |
| TO THE ORDER OF | BOTSWANA | $8.5K | 3 |
| M/S. MAKIZ PHARMA LIMITED | RUSSIA | $104 | 2 |
| M S TO THE ORDER OFCAMBER FARMACEUTICA LIMITED A | BRAZIL | $0 | 6 |
Hetero Labs Limited supplies Sitagliptin to 9 buyers globally. The largest buyer is XXAROXXPHAXXA XXA XX C XX (MEXICO), followed by XXAROXXPHAXXA SXX DXXC VX (MEXICO) and XXAROXXLIMXXED (UNITED KINGDOM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Sitagliptin Export Value and How Much Does Hetero Labs Limited Contribute?
India exported $46.1M worth of Sitagliptin through 5,364 shipments from 309 suppliers to 121 countries, serving 575 buyers globally. Hetero Labs Limited contributes $2.8M to this total, accounting for 3.7% of India's Sitagliptin exports. Hetero Labs Limited ships Sitagliptin to 7 countries through 9 buyers.
What Is the Average Shipment Value for Hetero Labs Limited's Sitagliptin Exports?
Hetero Labs Limited's average Sitagliptin shipment value is $50.0K per consignment, based on 56 shipments totaling $2.8M. The largest destination is MEXICO (86.0% of Hetero Labs Limited's Sitagliptin exports).
How Does Hetero Labs Limited Compare to Other Indian Sitagliptin Exporters?
Hetero Labs Limited ranks #4 among 309 Indian Sitagliptin exporters with a 3.7% market share. The top 3 exporters are DR.REDDY'S LABORATORIES LTD ($7.7M), MYLAN LABORATORIES LIMITED ($7.0M), SANDOZ PRIVATE LIMITED ($6.5M). Hetero Labs Limited processed 56 shipments to 7 destination countries.
What Sitagliptin Formulations Does Hetero Labs Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| SITAGLIPTIN / METFORMIN HCL 50/850MG | $700.0K | 14 |
| SITAGLIPTIN 100MG TABLETS (2X14'S) | $533.4K | 11 |
| SITAGLIPTIN PHOSPHATE 100MG TABLETS | $150.0K | 3 |
| SITAGLIPTIN/METFORMIN HCL | $100.0K | 2 |
| SITAGLIPTIN/METFORMIN HCL 50/850MG | $100.0K | 2 |
| SITAGLIPTIN 100MG TABLETS | $70.7K | 2 |
| SITAGLIPTINE PHOSPHATE 100MG TABLETS | $50.0K | 1 |
| SITAGLIPTINE PHOSPHATE 50MG TABLETS | $47.1K | 2 |
| SITAGLIPTIN 50MG TABLETS (2X14'S) | $24.4K | 1 |
| SITAGLIPTIN 25MG TABLETS (2X14'S) | $24.3K | 4 |
Hetero Labs Limited exports 23 distinct Sitagliptin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is SITAGLIPTIN / METFORMIN HCL 50/850MG with 14 shipments worth $700.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Sitagliptin to Key Markets
What Hetero Labs Limited must comply with to export Sitagliptin to its top destination countries
Mexico — COFEPRIS
Approval Process
Generic registration under Mexican health law. NOM standards apply.
Timeline: 12–18 months
GMP & Export Requirements
Mexican GMP (NOM-059-SSA1); COFEPRIS overseas inspection or PIC/S certificate
Sanitary Import Permit from COFEPRIS; import licence via SAT
Note: COFEPRIS participates in PIC/S, easing recognition of PIC/S certificates from Indian authorities.
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Hetero Labs Limited Compare to Nearest Sitagliptin Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | MSN LABORATORIES PRIVATE LIMITED | $3.2M | 78 | 1 | $41.6K |
| 9 | AUROBINDO PHARMA LIMITED | $2.9M | 63 | 4 | $46.4K |
| 4 | HETERO LABS LIMITED ★ | $2.8M | 56 | 7 | $50.0K |
| 5 | FREDUN PHARMACEUTICALS LTD | $2.8M | 56 | 1 | $50.0K |
| 11 | BETA DRUGS LIMITED | $2.4M | 85 | 1 | $28.6K |
Hetero Labs Limited ranks #4 among 309 Indian Sitagliptin exporters. Average shipment value of $50.0K compared to the market average of $149.3K. The closest competitors by value are MSN LABORATORIES PRIVATE LIMITED and AUROBINDO PHARMA LIMITED.
Which Indian Ports Ship Sitagliptin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 772 | 14.4% |
| DELHI AIR CARGO ACC (INDEL4) | 739 | 13.8% |
| SAHAR AIR | 735 | 13.7% |
| DELHI AIR | 513 | 9.6% |
| NHAVA SHEVA SEA (INNSA1) | 217 | 4.0% |
| HYDERABAD AIR | 213 | 4.0% |
| Bombay Air | 196 | 3.7% |
| HYDERABAD ACC (INHYD4) | 191 | 3.6% |
Geopolitical & Trade Policy Impact on Hetero Labs Limited's Sitagliptin Exports
The current geopolitical climate presents both challenges and opportunities for Hetero Labs Limited. The Israel-Iran tensions have led to increased risks in the Red Sea shipping routes, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation in shipping costs directly impacts Indian pharmaceutical exporters like Hetero, potentially eroding profit margins and necessitating strategic adjustments in logistics and pricing strategies.
Conversely, the U.S.-China trade tensions have created openings for Indian pharmaceutical companies. The U.S. has imposed tariffs as high as 245% on APIs from certain countries, leading to a reshoring of pharmaceutical manufacturing. Indian firms, including Hetero, have responded by investing in U.S. facilities, with outbound foreign direct investment estimated between $500-700 million during the partial FY 2025-26. This strategic move not only circumvents tariffs but also strengthens Hetero's presence in the lucrative U.S. market.
The recent India-European Union Free Trade Agreement (FTA), concluded in January 2026, eliminates tariffs on Indian pharmaceuticals entering the EU. This development enhances Hetero's competitiveness in the European market, providing a significant boost to its export potential. However, compliance with the EU's Falsified Medicines Directive remains imperative, necessitating stringent quality controls and traceability measures to maintain market access.
Hetero Labs Limited — Regulatory Compliance & Quality Standards
Regulatory compliance is paramount for Hetero's sustained success in international markets. In October 2025, the U.S. Food and Drug Administration (FDA) issued a Form 483 to Hetero's Nakkapalli facility in Andhra Pradesh, citing six major compliance lapses, including quality control deficiencies and improper documentation practices. Such observations can jeopardize Hetero's ability to supply APIs and antiretroviral drugs to the U.S. market, underscoring the critical need for rigorous adherence to Good Manufacturing Practices (GMP) and prompt corrective actions to address regulatory concerns.
About Hetero Labs Limited
Hetero Labs Limited exports 46 products worth $319.3M. Beyond Sitagliptin, top products include Tenofovir, Dolutegravir, Ritonavir, Acyclovir, Valacyclovir. View the complete Hetero Labs Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Sitagliptin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Sitagliptin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Hetero Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 56 individual customs records matching Hetero Labs Limited exporting Sitagliptin, covering 23 formulations to 7 countries via 9 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 121+ countries, 575+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Sitagliptin Export Data from Hetero Labs Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Hetero Labs Limited's Sitagliptin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Hetero Labs Limited
Full Company Profile →
46 products · $319.3M total trade · 18 categories
Sitagliptin Stats
Company Overview
Top Products by Hetero Labs Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Hetero Labs Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Sitagliptin. For current shipment-level data, contact TransData Nexus.